Clinical trial
TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure…
NCT00345592 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00345592 |
|---|---|
| Title | TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients |
| Official title | TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients |
| Acronym | TRADE HF |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Device |
| Interventions | Dual (atrial and ventricular) implantable defibrillator |
| Enrollment | 420 |
| Start date | Oct 1, 2006 |
| Primary completion | Nov 1, 2012 |
| Completion | Nov 1, 2012 |
| First posted | Jun 28, 2006 |
| Last update posted | Mar 28, 2017 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: